Actuate Therapeutics ACTU
NASDAQ ACTU
$0.78 +0.09 (+13.66%)
At close: Sep 30, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Accounts Payables (2023 - 2026)

Updated

Actuate Therapeutics' Accounts Payables came in at $1.08 million for Q2 2026, down 66.0% from $3.17 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Accounts Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics' Accounts Payables was $1.52 million, down 20.7% from FY2024.

  • Going back by year, Accounts Payables was $1.92 million in FY2024 (-43.9%) and $3.42 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Accounts Payables in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Actuate Therapeutics 16.57 Mn 16.57 Mn - 1.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Mn
Dec 31, 2025 1.52 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 3.17 Mn
Mar 31, 2025 2.64 Mn
Dec 31, 2024 1.92 Mn
Sep 30, 2024 2.33 Mn
Jun 30, 2024 5.89 Mn
Dec 31, 2023 3.42 Mn
API Access

Actuate Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ACTU&period=max&api_key=YOUR_API_KEY